SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-252199
Filing Date
2024-11-06
Accepted
2024-11-06 17:14:40
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d858933ds3.htm S-3 311760
2 EX-4.6 d858933dex46.htm EX-4.6 290156
3 EX-5.1 d858933dex51.htm EX-5.1 27990
4 EX-23.1 d858933dex231.htm EX-23.1 1747
5 EX-FILING FEES d858933dexfilingfees.htm EX-FILING FEES 59339
6 GRAPHIC g858933dsp100.jpg GRAPHIC 3011
7 GRAPHIC g858933dsp99.jpg GRAPHIC 3994
8 GRAPHIC g858933g03k03.jpg GRAPHIC 47873
  Complete submission text file 0001193125-24-252199.txt   767921
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283041 | Film No.: 241432201
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)